Systolic Blood Pressure, Cardiovascular Mortality, and All-Cause Mortality in Normoglycemia, Prediabetes, and Diabetes

References

• Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40. doi:10.1016/s0140-6736(11)60679-x
   PubMed Web of Science ®Google Scholar
• Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16:434–444. doi:10.2337/diacare.16.2.434
   PubMed Web of Science ®Google Scholar
• Hubbard D, Colantonio LD, Tanner RM, et al. Prediabetes and risk for cardiovascular disease by hypertension status in black adults: the Jackson Heart Study. Diabetes Care. 2019;42:2322–2329. doi:10.2337/dc19-1074
   PubMedGoogle Scholar
• Huang Y, Cai X, Mai W, et al. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953. doi:10.1136/bmj.i5953
   PubMed Web of Science ®Google Scholar
• Morris DH, Khunti K, Achana F, et al. Progression rates from HbA1c 6.0–6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia. 2013;56:1489–1493. doi:10.1007/s00125-013-2902-4
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78:305–312. doi:10.1016/j.diabres.2007.05.004
   PubMed Web of Science ®Google Scholar
• Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403. doi:10.1056/NEJMoa012512
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350. doi:10.1056/nejm200105033441801
   PubMed Web of Science ®Google Scholar
• Liu HH, Cao YX, Li S, et al. Impacts of prediabetes mellitus alone or plus hypertension on the coronary severity and cardiovascular outcomes. Hypertension. 2018;71:1039–1046. doi:10.1161/hypertensionaha.118.11063
   PubMed Web of Science ®Google Scholar
• Qiu M, Shen W, Song X, et al. Effects of prediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus: longitudinal study. Hypertension. 2015;65:525–530. doi:10.1161/hypertensionaha.114.04632
   PubMedGoogle Scholar
• Hadaegh F, Derakhshan A, Zafari N, et al. Pre-diabetes tsunami: incidence rates and risk factors of pre-diabetes and its different phenotypes over 9 years of follow-up. Diabet Med. 2017;34:69–78. doi:10.1111/dme.13034
   PubMed Web of Science ®Google Scholar
• Bullard KM, Saydah SH, Imperatore G, et al. Secular changes in U.S. Prediabetes prevalence defined by hemoglobin A1c and fasting plasma glucose: national health and nutrition examination surveys, 1999–2010. Diabetes Care. 2013;36:2286–2293. doi:10.2337/dc12-2563
   PubMedGoogle Scholar
• Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–967. doi:10.1016/s0140-6736(15)01225-8
   PubMed Web of Science ®Google Scholar
• Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61–68. doi:10.1001/jama.2010.884
   PubMed Web of Science ®Google Scholar
• Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–1585. doi:10.1056/NEJMoa1001286
   PubMed Web of Science ®Google Scholar
• Wright JT, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–2116. doi:10.1056/NEJMoa1511939
   PubMed Web of Science ®Google Scholar
• Vidal-Petiot E, Ford I, Greenlaw N, et al. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study. Lancet. 2016;388:2142–2152. doi:10.1016/s0140-6736(16)31326-5
   PubMed Web of Science ®Google Scholar
• Reboldi G, Gentile G, Angeli F, et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens. 2011;29:1253–1269. doi:10.1097/HJH.0b013e3283469976
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kumar S, Lobach I, et al. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials. Circulation. 2011;123:2799–2810, 2799 p following 2810. doi:10.1161/circulationaha.110.016337
   PubMed Web of Science ®Google Scholar
• Tian J, Sheng CS, Sun W, et al. Effects of high blood pressure on cardiovascular disease events among Chinese adults with different glucose metabolism. Diabetes Care. 2018;41:1895–1900. doi:10.2337/dc18-0918
   PubMed Web of Science ®Google Scholar
• Bress AP, King JB, Kreider KE, et al. Effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial. Diabetes Care. 2017;40:1401–1408. doi:10.2337/dc17-0885
   PubMed Web of Science ®Google Scholar
• Ali MK, Bullard KM, Saydah S, et al. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988–2014. Lancet Diabetes Endocrinol. 2018;6:392–403. doi:10.1016/s2213-8587(18)30027-5
   PubMed Web of Science ®Google Scholar
• Bao W, Liu B, Simonsen DW, et al. Association between exposure to pyrethroid insecticides and risk of all-cause and cause-specific mortality in the general US adult population. JAMA Intern Med. 2020;180:367–374. doi:10.1001/jamainternmed.2019.6019
   PubMed Web of Science ®Google Scholar
• Palta P, Huang ES, Kalyani RR, et al. Hemoglobin A(1c) and mortality in older adults with and without diabetes: results from the national health and nutrition examination surveys (1988–2011). Diabetes Care. 2017;40:453–460. doi:10.2337/dci16-0042
   PubMed Web of Science ®Google Scholar
• Fain JA. NHANES. Diabetes Educ. 2017;43:151. doi:10.1177/0145721717698651
   PubMedGoogle Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2018;71:e12–e248. doi:10.1016/j.jacc.2017.11.006
   PubMedGoogle Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43:S14–S31. doi:10.2337/dc20-S002
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. 2011 Public-use linked mortality files. Available from: https://www.cdc.gov/nchs/data/datalinkage/2011_linked_mortality_file_matching_methodology.pdf. Accessed December 20, 2019.
   Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266.
   PubMed Web of Science ®Google Scholar
• Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality: a systematic review and network meta-analysis. JAMA Cardiol. 2017;2:775–781. doi:10.1001/jamacardio.2017.1421
   PubMed Web of Science ®Google Scholar
• Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352:i717. doi:10.1136/bmj.i717
   PubMed Web of Science ®Google Scholar
• Li W, Katzmarzyk PT, Horswell R, et al. Blood pressure and all-cause mortality among patients with type 2 diabetes. Int J Cardiol. 2016;206:116–121. doi:10.1016/j.ijcard.2016.01.009
   PubMedGoogle Scholar
• Adamsson Eryd S, Gudbjörnsdottir S, Manhem K, et al. Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study. BMJ. 2016;354:i4070. doi:10.1136/bmj.i4070
   PubMedGoogle Scholar
• Sundström J, Sheikhi R, Ostgren CJ, et al. Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients. J Hypertens. 2013;31:1603–1610. doi:10.1097/HJH.0b013e32836123aa
   PubMed Web of Science ®Google Scholar
• Banach M, Aronow WS. Blood pressure j-curve: current concepts. Curr Hypertens Rep. 2012;14:556–566. doi:10.1007/s11906-012-0314-3
   PubMed Web of Science ®Google Scholar
• Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. J Hypertens. 2017;35:922–944. doi:10.1097/hjh.0000000000001276
   PubMed Web of Science ®Google Scholar
• Emanuelsson F, Marott S, Tybjærg-Hansen A, et al. Impact of glucose level on micro- and macrovascular disease in the general population: a mendelian randomization study. Diabetes Care. 2020;43:894–902. doi:10.2337/dc19-1850
   PubMedGoogle Scholar
• Siu AL. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. preventive services task force recommendation statement. Ann Intern Med. 2015;163:861–868. doi:10.7326/m15-2345
   PubMed Web of Science ®Google Scholar
• Hajebrahimi MA, Akbarpour S, Eslami A, et al. Different combinations of glucose tolerance and blood pressure status and incident cardiovascular disease and all-cause mortality events. J Hum Hypertens. 2017;31:744–749. doi:10.1038/jhh.2017.49
   PubMedGoogle Scholar
• Roumie CL, Hung AM, Russell GB, et al. Blood pressure control and the association with diabetes mellitus incidence: results from SPRINT randomized trial. Hypertension. 2020;75:331–338. doi:10.1161/hypertensionaha.118.12572
   PubMedGoogle Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document. J Hypertens. 2009;27:2121–2158. doi:10.1097/HJH.0b013e328333146d
   PubMed Web of Science ®Google Scholar
• Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387:435–443. doi:10.1016/s0140-6736(15)00805-3
   PubMed Web of Science ®Google Scholar